Search
Now showing items 1-8 of 8
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 disease
(2020-07-07)Background: Some people with SARS‐CoV‐2 infection remain asymptomatic, whilst in others the infection can cause mild to moderate COVID‐19 disease and COVID‐19 pneumonia, leading some patients to require intensive care ... -
Cerebrolysin for acute ischaemic stroke
(2020-07-14)Background: Cerebrolysin is a mixture of low‐molecular‐weight peptides and amino acids derived from porcine brain that has potential neuroprotective properties. It is widely used in the treatment of acute ischaemic stroke ... -
Pruebas de anticuerpos para identificar infecciones pasadas o presentes por SARS‐CoV‐2
(2020-06-25)Antecedentes: El virus SARS‐CoV‐2 (síndrome respiratorio agudo grave coronavirus 2) y la pandemia de covid‐19 resultante presentan importantes retos de diagnóstico. Hay varias estrategias de diagnóstico disponibles para ... -
What are the risk factors and effectiveness of prophylaxis for venous thromboembolism in COVID-19 patients?
(2020-07-10)BACKGROUND: An emerging issue in the management of the novel COVID-19 coronavirus is morbidity and mortality associated with venous thrombolytic events. Apart from respiratory failure, coagulopathy is a common abnormality ... -
Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives
(2020-06-30)A life-threatening respiratory illness (COVID-19) due to severe acute respiratory syndrome (SARS)-CoV-2 coronavirus was first described in December 2019 in Wuhan (China), rapidly evolving into a pandemic. In the first ... -
Azithromycine : les effets sur le traitement de COVID-19 sont incertains
(2020-07-16)Citation: Gbinigie K, Frie K. Should azithromycin be used to treat COVID-19? A rapid review. BJGP open. 2020 Jun 23;4(2):bjgpopen20X101094 Quel est le contenu ? Azithromycine a été suggéré comme traitement possible pour ... -
COVID-19 and smoking: A systematic review of the evidence
(2020)COVID-19 is a coronavirus outbreak that initially appeared in Wuhan, Hubei Province, China, in December 2019, but it has already evolved into a pandemic spreading rapidly worldwide1,2. As of 18 March 2020, a total number ... -
Prise en charge chirurgicale des cancers gynécologiques en période de pandémie COVID-19 – Recommandations du Groupe FRANCOGYN pour le CNGOFGuidelines for surgical management of gynaecological cancer during pandemic COVID-19 period – FRANCOGYN group for the CNGOF
(2020-03-25)Introduction : Proposer des recommandations de prise en charge des patientes atteintes de cancer gynécologique dans la période de pandémie du COVID-19. Matériel et méthode : Recommandations sur le modèle des conférences ...